APELLIS PHARMACEUTICALS INC's ticker is APLS and the CUSIP is 03753U106. A total of 217 filers reported holding APELLIS PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.07 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $418 | -7.5% | 10,998 | +121.6% | 0.03% | -11.1% |
| Q2 2023 | $452 | +10.5% | 4,963 | -20.0% | 0.04% | +20.0% |
| Q1 2023 | $409 | -8.1% | 6,207 | -27.9% | 0.03% | -18.9% |
| Q4 2022 | $445 | -99.9% | 8,604 | +22.0% | 0.04% | -17.8% |
| Q3 2022 | $482,000 | 0.0% | 7,050 | -33.8% | 0.04% | +2.3% |
| Q2 2022 | $482,000 | +53.0% | 10,651 | +71.9% | 0.04% | +340.0% |
| Q1 2022 | $315,000 | – | 6,196 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 2,503,059 | $170,959,000 | 29.50% |
| ACUTA CAPITAL PARTNERS, LLC | 554,000 | $37,838,000 | 16.29% |
| Avoro Capital Advisors LLC | 10,125,000 | $691,538,000 | 12.78% |
| Sio Capital Management, LLC | 507,700 | $34,676,000 | 11.02% |
| Logos Global Management LP | 1,300,000 | $88,790,000 | 10.92% |
| EcoR1 Capital, LLC | 5,183,431 | $354,028,000 | 10.45% |
| Cormorant Asset Management, LP | 1,478,000 | $100,947,000 | 7.06% |
| Finepoint Capital LP | 266,090 | $18,174,000 | 5.98% |
| Ghost Tree Capital, LLC | 275,000 | $18,783,000 | 5.27% |
| Boxer Capital, LLC | 1,303,700 | $89,043,000 | 5.01% |